ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results

Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, EnglandHosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, ArgentinaHEMORIO, Rio de Janeiro, BrazilMt Sinai Hosp, New York, NY 10029 USACincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USAUniversidade Federal de São Paulo, São Paulo, BrazilMinist Publ Hlth Russia, Hematol Res Ctr, Moscow, RussiaCedars Sinai Tower Hematol Oncol Med Grp, Beverly Hills, CA USAGenzyme, Cambridge, MA USAUniversidade Federal de São Paulo, São Paulo, BrazilWeb of Scienc